Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Non Operating Income (2024 - 2025)

Updated

Innocan Pharma's Non Operating Income was $27,000 in the year ended Dec 31, 2025, compared with -$49,000 a year earlier.

Analysis

Innocan Pharma (INNPF) Non Operating Income (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Non Operating Income in earlier years was -$49,000 in the year ended Dec 31, 2024 and $27,000 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -130.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 86,000.00
Mar 31, 2025 10,000.00
Jun 30, 2024 155,000.00
Mar 31, 2024 -50,000.00
API Access

Innocan Pharma Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=INNPF&period=max&api_key=YOUR_API_KEY